Craig C. Hopkinson, EVP R&D, Chief Medical Officer at Alkermes plc. (ALKS), sold 9,000 shares at $41.67 ($375K) on 2026-06-01, disclosed to the SEC on 2026-06-01.
Scheduled sale ($375k) by EVP R&D, Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ALKS | SELL | 2026-07-01 | $464K | — | Filing → |
| ALKS | SELL | 2026-05-01 | $301K | — | Filing → |
| ALKS | SELL | 2026-04-01 | $320K | — | Filing → |